Method for freezing and unfreezing early buffalo embryo containing forsythin

By using forsythia glycoside-containing freezing solution during buffalo embryo freezing, the freezing process is optimized, and the problems of complexity of traditional embryo freezing methods and insufficient cell protection are solved, which significantly improves the resuscitation and hatching rate of embryos, and achieves high efficiency. Safe embryo preservation.

CN119054682APending Publication Date: 2024-12-03HUANGS SAIER BIOTECHNOLOGY (GUANGXI) CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411179552.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

Traditional embryo freezing methods are complex in operation, time-consuming and easy to form ice crystals, which affects the survival rate and development potential of embryos. The selection and use of cryoprotective agents in the existing vitrification cryogenic technology lead to poor cell protection effect during embryo freezing.

Method used

Using frozen balance solution, freezing solution and thawing solution containing forsythin glycoside, the freezing and thawing process can be optimized to improve the freezing and thawing resuscitation rate and hatching rate of early buffalo embryos. The specific steps include freezing and thawing treatment of embryos in the blastocyst stage. TCM-199 culture medium containing forsythiatin was used as the freezing, equilibration and thawing solution.

Benefits of technology

The resuscitation rate and hatching rate of early buffalo embryos after freezing and thawing are significantly improved. The application of forsythia glycoside makes embryos more efficient and safe, with a moderate price and easy to obtain, making it easy to promote and apply.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119054682A_ABST
    Figure CN119054682A_ABST
Patent Text Reader

Abstract

The invention discloses a phillyrin-containing buffalo early embryo freezing and unfreezing method, a certain amount of phillyrin is added into a freezing equilibrium liquid, a freezing liquid and an unfreezing liquid, the recovery rate and hatching rate of the buffalo embryo after freezing and unfreezing can be significantly improved, in addition, phillyrin is moderate in price and easy to obtain, and the phillyrin is suitable for large-scale popularization and application. And the method is convenient to widely popularize and apply in in-vitro production of a buffalo embryo freezing technology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biotechnology, and in particular to a method for freezing and thawing early buffalo embryos containing forsythiaside. Background Art

[0002] In the field of animal husbandry and biomedical research, embryo cryopreservation technology is a crucial technology. It is of great significance for the long-term preservation of excellent genetic resources, cross-regional transportation, and the improvement of animal reproduction efficiency. Traditional embryo freezing methods, such as conventional slow freezing, can achieve low-temperature preservation of embryos, but their operation is complicated and time-consuming, and ice crystals are easily formed during the freezing process, causing damage to the embryos, thereby affecting the survival rate and developmental potential of the embryos after thawing.

[0003] In recent years, vitrification technology has gradually become the mainstream method for embryo cryopreservation because of its simple and rapid operation and ability to effectively reduce ice crystal formation. Vitrification rapidly dehydrates cells by adding high concentrations of cryoprotectants and directly immerses them in liquid nitrogen at a high temperature, causing the cryosol to quickly solidify into a glassy state, thereby avoiding the formation of ice crystals and protecting the integrity of the embryo.

[0004] In the vitrification technology, the selection and use of cryoprotectants is a crucial link. Forsythiaside is the key active compound of the traditional Chinese medicine Forsythia suspensa, which has anti-tumor, antioxidant, and anti-inflammatory effects. Studies have shown that it has great potential in anti-tumor. However, despite the excellent performance of forsythiaside in antioxidant and cell protection, its application in embryo cryopreservation has rarely been reported.

[0005] Therefore, the present invention aims to provide a method for freezing and thawing early buffalo embryos containing forsythiaside, and to achieve efficient and safe preservation of early buffalo embryos by optimizing the formula of cryoprotectants and the freezing and thawing process, thereby providing strong support for animal husbandry production and scientific research. Summary of the invention

[0006] The purpose of the present invention is to overcome the shortcomings of the prior art and provide a method for freezing and thawing early buffalo embryos containing forsythiaside, as well as a matching freezing balance solution and thawing solution, which can improve the recovery rate and hatching rate of early buffalo embryos after freezing and thawing.

[0007] To achieve the above purpose, the technical solution provided by the present invention is as follows:

[0008] A method for freezing and thawing early buffalo embryos containing forsythiaside comprises the following steps:

[0009] Step S1, freezing: collect the early buffalo embryos that have developed to the blastocyst stage, place them in physiological saline for standby use, first place the early buffalo embryos in a freezing base solution for 3 to 7 minutes, then transfer them to a freezing equilibrium solution for 0.5 to 1.5 minutes, and then transfer them to a freezing solution, then transfer the early buffalo embryos and the freezing solution droplets to the front end of a Cryotop carrier, and then put the Cryotop carrier into liquid nitrogen;

[0010] Step S2, thawing: immerse the Cryotop carrier frozen with buffalo early embryos in a thawing solution at 37.5-39.5° C. for 4-6 minutes, then transfer the embryos to a freezing base solution at 37.5-39.5° C. for 4-6 minutes, then transfer the embryos to a new freezing base solution and recover in an environment of 37.5-39.5° C. and 3-6% CO2 for 1-1.5 hours.

[0011] Wherein, the freezing base liquid is TCM-199 culture liquid containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3 and sodium pyruvate.

[0012] The frozen equilibrium solution contains forsythiaside and a solvent, and the solvent is a TCM-199 culture medium containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, dimethyl sulfoxide, ethylene glycol, and fetal bovine serum.

[0013] The freezing liquid comprises forsythiaside and a solvent, wherein the solvent comprises 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO 3、 TCM-199 culture medium containing sodium pyruvate, dimethyl sulfoxide, ethylene glycol, sucrose, and fetal bovine serum.

[0014] The thawing solution contains forsythiaside and a solvent, and the solvent is a TCM-199 culture medium containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, sucrose, and fetal bovine serum.

[0015] Preferably, in the freezing base liquid, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, and the concentration of sodium pyruvate is 0.056 g / L.

[0016] Preferably, in the frozen equilibrium solution, the molar concentration of forsythiaside in the solvent is 2.5 μM.

[0017] Preferably, in the solvent of the frozen equilibrium solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the mass percentage of dimethyl sulfoxide is 10%, the mass percentage of ethylene glycol is 10%, and the mass percentage of fetal bovine serum is 20%.

[0018] Preferably, in the frozen solution, the molar concentration of forsythiaside in the solvent is 2.5 μM.

[0019] Preferably, in the solvent of the freezing liquid, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the mass percentage of dimethyl sulfoxide is 20%, the mass percentage of ethylene glycol is 20%, the molar concentration of sucrose is 0.5 mol / L, and the mass percentage of fetal bovine serum is 20%.

[0020] Preferably, in the thawing solution, the molar concentration of forsythiaside in the solvent is 2.5 μM.

[0021] Preferably, in the solvent of the thawing solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the molar concentration of sucrose is 0.5 mol / L, and the mass percentage of fetal bovine serum is 20%. Compared with the prior art, the present invention has the following beneficial effects:

[0022] The present invention provides a method for freezing and thawing early-stage buffalo embryos containing forsythiaside, as well as matching freezing balance solution and thawing solution. The present invention applies forsythiaside to freezing of early-stage buffalo embryos, which can significantly improve the recovery rate and hatching rate of buffalo embryos after freezing and thawing. In addition, forsythiaside is moderately priced and easy to obtain, so it is convenient to be widely promoted and applied in the in vitro production of buffalo embryo freezing technology.

[0023] Instruction Manual

[0024] Figure 1 This is a photo of the development of early buffalo embryos after thawing;

[0025] In the figure, A is the control group, B is the 2.5 μM forsythiaside group, and C is the 20 μM forsythiaside group. DETAILED DESCRIPTION

[0026] The following is a detailed description in conjunction with specific embodiments, but it should be understood that the scope of protection of the present invention is not limited by the specific embodiments. The raw materials used in the examples are all commercially available unless otherwise specified.

[0027] Example 1 Freezing and Thawing Method of Buffalo Early Embryos

[0028] 1. Test methods

[0029] Freezing: Collect 2-3 early buffalo embryos that have developed to the blastocyst stage and place them in physiological saline for later use. First, place the early buffalo embryos in the freezing base solution for 5 minutes, then transfer them to the freezing balance solution for 1 minute, and then transfer them into the freezing solution. Then, drop the early buffalo embryos and the freezing solution to the front end of the Cryotop carrier, and then quickly put the Cryotop carrier into liquid nitrogen. The process of drop transfer and immersion in liquid nitrogen should be completed within 30 seconds.

[0030] Thawing: Take out the Cryotop carrier containing frozen buffalo early embryos from liquid nitrogen, quickly immerse it in 38.5℃ thawing solution for 5 minutes, then transfer the embryos to 38.5℃ freezing base solution for 5 minutes, then transfer the embryos to new freezing base solution and recover for 1.2 hours in an incubator at 38.5℃, 5% CO2, and maximum saturated humidity.

[0031] The formula of the freezing base solution is: TCM-199 culture medium containing 5.96 g / L 4-hydroxyethylpiperazineethanesulfonic acid, 1.25 g / L NaHCO3 and 0.056 g / L sodium pyruvate;

[0032] The experiment was divided into a control group, a 2.5 μM forsythiaside group and a 20 μM forsythiaside group. The formulas of the freezing balance solution, freezing solution and thawing solution used in each group are shown in Tables 1 to 9:

[0033] Table 1: Formula of frozen balance solution for control group

[0034]

[0035] Table 2 Freezing liquid formula of control group

[0036]

[0037] Table 3 Thawing solution formula of the control group

[0038]

[0039]

[0040] Table 4 Formula of frozen equilibrium solution of 2.5 μM forsythiaside group

[0041]

[0042] Table 5 Freezing solution formula of 2.5 μM forsythiaside group

[0043]

[0044] Table 6 Thawing solution formula of 2.5 μM forsythiaside group

[0045]

[0046]

[0047] Table 7 Formula of frozen equilibrium solution of 2.5 μM forsythiaside group

[0048]

[0049] Table 8 Freezing solution formula of 2.5 μM forsythiaside group

[0050]

[0051] Table 9 Thawing solution formula of 2.5 μM forsythiaside group

[0052]

[0053]

[0054] 2. Test results

[0055] The recovery rate and hatching rate of thawed embryos were statistically analyzed. The results are shown in Table 7 and Figure 1 As shown, the recovery rate of 89.65% in the 2.5 μM forsythiaside group was significantly higher than 80.82% in the control group and 85.29% in the 20 μM forsythiaside group. The hatching rate of 71.79% was significantly higher than 62.71% in the control group and 67.24% in the 20 μM forsythiaside group.

[0056] Table 7 Recovery rate and hatching rate of thawed embryos

[0057]

[0058] Note: Numbers with different letters in the same column indicate significant differences (P<0.05).

[0059] The results showed that adding 2.5 μM forsythiaside to the freezing balance solution and thawing solution could improve the recovery rate and hatching rate of early buffalo embryos after freezing and thawing.

[0060] The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.

Claims

1. A method for freezing and thawing early buffalo embryos containing forsythiaside, characterized in that: The following steps are involved: Step S1, freezing: collecting early buffalo embryos that have developed to the blastocyst stage, placing them in physiological saline for standby use, first placing the early buffalo embryos in a freezing base solution for 3 to 7 minutes, then transferring them to a freezing equilibrium solution for 0.5 to 1.5 minutes, and then transferring them to a freezing solution, and then transferring the early buffalo embryos and the freezing solution droplets to the front end of a Cryotop carrier, and then immersing the Cryotop carrier in liquid nitrogen; Step S2, thawing: immerse the Cryotop carrier frozen with buffalo early embryos in a thawing solution at 37.5-39.5° C. for 4-6 minutes, then transfer the embryos to a freezing base solution at 37.5-39.5° C. for 4-6 minutes, then transfer the embryos to a new freezing base solution and recover in an environment of 37.5-39.5° C. and 3-6% CO2 for 1-1.5 hours. The freezing base solution is a TCM-199 culture solution containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3 and sodium pyruvate; The freezing liquid comprises forsythiaside and a solvent, wherein the solvent comprises 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO 3、 TCM-199 culture medium containing sodium pyruvate, dimethyl sulfoxide, ethylene glycol, sucrose, and fetal bovine serum; The frozen equilibrium solution comprises forsythiaside and a solvent, wherein the solvent is a TCM-199 culture medium containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, dimethyl sulfoxide, ethylene glycol, and fetal bovine serum; The thawing solution contains forsythiaside and a solvent, and the solvent is a TCM-199 culture solution containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, sucrose, and fetal bovine serum.

2. The method according to claim 1, characterized in that: In the freezing base liquid, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, and the concentration of sodium pyruvate is 0.056 g / L; in the freezing liquid, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the mass percentage of dimethyl sulfoxide is 20%, the mass percentage of ethylene glycol is 20%, the molar concentration of sucrose is 0.5 mol / L, and the mass percentage of fetal bovine serum is 20%.

3. The method according to claim 1, characterized in that: In the frozen equilibrium solution, the molar concentration of forsythiaside in the solvent was 2.5 μM; in the frozen solution, the molar concentration of forsythiaside in the solvent was 2.5 μM; in the thawed solution, the molar concentration of forsythiaside in the solvent was 2.5 μM.

4. The method according to claim 1, characterized in that: In the solvent of the frozen equilibrium solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the mass percentage of dimethyl sulfoxide is 10%, the mass percentage of ethylene glycol is 10%, and the mass percentage of fetal bovine serum is 20%.

5. The method according to claim 1, characterized in that: In the solvent of the freezing solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the molar concentration of sucrose is 0.5 mol / L, the mass percentage of dimethyl sulfoxide is 10%, the mass percentage of ethylene glycol is 10%, and the mass percentage of fetal bovine serum is 20%.

6. The method according to claim 1, characterized in that: In the solvent of the thawing solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the molar concentration of sucrose is 0.5 mol / L, and the mass percentage of fetal bovine serum is 20%.

7. A buffalo early embryo freezing equilibrium solution containing forsythiaside, characterized in that: The buffalo early embryo freezing equilibrium solution contains forsythiaside and a solvent, and the solvent is a TCM-199 culture solution containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, dimethyl sulfoxide, ethylene glycol, and fetal bovine serum.

8. The buffalo early embryo freezing equilibrium solution according to claim 7, characterized in that: In the frozen equilibrium solution, the molar concentration of forsythiaside in the solvent is 2.5 μM; in the solvent of the frozen equilibrium solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the mass percentage of dimethyl sulfoxide is 10%, the mass percentage of ethylene glycol is 10%, and the mass percentage of fetal bovine serum is 20%.

9. A buffalo early embryo thawing solution containing forsythiaside, characterized in that: The buffalo early embryo thawing solution contains forsythiaside and a solvent, and the solvent is a TCM-199 culture solution containing 4-hydroxyethylpiperazineethanesulfonic acid, NaHCO3, sodium pyruvate, sucrose, and fetal bovine serum.

10. The buffalo early embryo thawing solution according to claim 9, characterized in that: In the thawing solution, the molar concentration of forsythiaside in the solvent is 2.5 μM; in the solvent of the thawing solution, the concentration of 4-hydroxyethylpiperazineethanesulfonic acid is 5.96 g / L, the concentration of NaHCO3 is 1.25 g / L, the concentration of sodium pyruvate is 0.056 g / L, the molar concentration of sucrose is 0.5 mol / L, and the mass percentage of fetal bovine serum is 20%.